We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

A Trial of Telemonitoring in Adults With Heart Failure

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: July 13, 2011
Last Update Posted: July 13, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospitals Cleveland Medical Center

This is a randomized controlled trial of telemonitoring vs usual care provided by home care agencies for atients with HF.

The study hypothesis is that Telemonitoring will reduce hospital re-admission rates, urgent care visits, unscheduled physician appointments, ER visits in patients with heart failure over the 60 day post hospitalization period.

Condition Intervention
Heart Failure Device: Honeywell HomMed Telemonitor

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial of Telemonitoring in Older Adults With Heart Failure

Resource links provided by NLM:

Further study details as provided by University Hospitals Cleveland Medical Center:

Primary Outcome Measures:
  • rehospitalization [ Time Frame: Particpants were followed for the duration of home care services up to 12 months ]

Secondary Outcome Measures:
  • health status [ Time Frame: Particpants were followed for the duration of home care services up to 12 months ]

Enrollment: 105
Study Start Date: November 2007
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Honeywell HomMed Telemonitor Device: Honeywell HomMed Telemonitor
telemonitoring post hospitalization
No Intervention: usual care


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • HF (primary or secondary) diagnosis regardless of ejection fraction (EF) and NYHA class II- IV at the time of HHC admission and HHC services initiated following a hospital stay

Exclusion Criteria:

  • inability to stand on a scale, weight over 500 lbs, unable to hear and/or see, or no working land line phone in the residence.
  • Additional exclusion criteria were: patients with severe ischemic heart disease, MI and/or CABG in the last 6 weeks, severe uncorrected valvular disease, home inotropic therapy, severe lung disease (oxygen dependent), active cancer, uncorrected thyroid disease, AIDS, or end stage renal disease on dialysis.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Rebecca Boxer, MD, Case Western Reserve University
ClinicalTrials.gov Identifier: NCT01393314     History of Changes
Other Study ID Numbers: 1KL2RR024990 - 2
1KL2RR024990 ( U.S. NIH Grant/Contract )
First Submitted: July 1, 2011
First Posted: July 13, 2011
Last Update Posted: July 13, 2011
Last Verified: June 2011

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases